Webinar Replay

Teen Depression and Anxiety: Could Ketamine be the Key to this Epidemic?

Due to the ongoing pandemic, depression and anxiety are at an all-time high — and teens and adolescents are especially likely to struggle with mental health even during the best of times. Tragically, one in four young adults contemplated suicide last year, according to the CDC. What are the treatment methods best suited for this vulnerable population? Can emerging alternative methods like ketamine-assisted therapy and other psychedelics be applicable to young people? What kind of risks and benefits need to be considered for this special demographic? In this sobering webinar, we’ll hear from leading experts in adolescent mental health on how the growing crisis can best be confronted using conventional and emerging mental health tools.

Meet the Experts

Colorado was one of the first states to decriminalize cannabis and in certain cities, psychedelics. Now the state as a whole is working toward decriminalization for psilocybin and other psychedelic medicines. Read more: https://coloradosun.com/2022/02/25/mushrooms-psychedelics-legalization-attempt-colorado/

Tapan Parikh, M.D., MPH

 Medical Director of Acute Care Services entral Division/National Medical Lead

Ann & Robert H. Lurie Children’s Hospital of Chicago

Aguirre, Blaise

Blaise Aguirre M.D.

Medical Director 3East McLean Hospital

Assistant Professor in Psychiatry Harvard Medical School

Mark Braunstein, DO

Mark Braunstein, DO

Child Adolescent and Adult Psychiatrist 

Medical Director at Tripsitter.Clinic

Erika Steinbrenner MD

Moderator: Erika Steinbrenner M.D.


Wesana Health